Parker et al., Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Every patient gets lab work, a provider consultation, and an evidence-based treatment plan
Your current weight 232 lbs Weight you could lose 48 lbs * This tool is for educational purposes based on clinical study averages
Emma F, Hoff WV, Hohenfellner K, Topaloglu R, Greco M, Ariceta G, Bettini C, Bockenhauer D, Veys K, Pape L, Hulton S, Collin S, Ozaltin F, Servais A, Deschenes G, Novo R, Bertholet-Thomas A, Oh J, Cornelissen E, Janssen M, Haffner D, Rava L, Antignac C, Devuyst O, Niaudet P, Levtchenko E (2021) An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis
The episode provides both warnings about AI's disruptive potential and practical guidance for thriving in the years ahead
Mochi Health dosage chart Mochi Health has gained attention as a telehealth platform prescribing compounded tirzepatide